Us2.ai was founded in 2017 by Dr Carolyn Lam, James Hare & Dr Yoran Hummel. The company specializes in Artificial Intelligence and is dedicated to automating the fight against heart disease through the development of deep learning solutions applied to ultrasound medical imaging biomarkers. Us2.ai is a fast-growing startup backed by IHH Healthcare, Heal Partners, Sequoia India and EDBI.
Us2.ai mission is to improve patient outcomes and expand healthcare access by democratizing echocardiograms – the most commonly used tool for the detection of heart risk – through the use of AI. Us2.ai is building a future where everyone, from the most advanced tech-driven regions to the most resource-constrained communities, can have equal access to high quality, consistent and inexpensive echo analysis.